This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehmann, J M
Right arrow Articles by Pfahl, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehmann, J M
Right arrow Articles by Pfahl, M

 Previous Article  |  Next Article 

Mol Cell Biol. 1993 December; 13(12): 7698-7707

Formation of retinoid X receptor homodimers leads to repression of T3 response: hormonal cross talk by ligand-induced squelching.

J M Lehmann, X K Zhang, G Graupner, M O Lee, T Hermann, B Hoffmann and M Pfahl

Cancer Center, La Jolla Cancer Research Foundation, California 92037.

ABSTRACT

Thyroid hormone receptors (TRs) form heterodimers with retinoid X receptors (RXRs). Heterodimerization is required for efficient TR DNA binding to most response elements and transcriptional activation by thyroid hormone. RXRs also function as auxiliary proteins for several other receptors. In addition, RXR alpha can be induced by specific ligands to form homodimers. Here we report that RXR-specific retinoids that induce RXR homodimers are effective repressors of the T3 response. We provide evidence that this repression by RXR-specific ligands occurs by sequestering of RXR from TR-RXR heterodimers into RXR homodimers. This ligand-induced squelching may represent an important mechanism by which RXR-specific retinoids and 9-cis retinoic acid mediate hormonal cross talk among a subfamily of nuclear receptors activated by structurally unrelated ligands.


Mol Cell Biol. 1993 December; 13(12): 7698-7707




This article has been cited by other articles:

  • Putcha, B.-D. K., Fernandez, E. J. (2009). Direct Interdomain Interactions Can Mediate Allosterism in the Thyroid Receptor. J. Biol. Chem. 284: 22517-22524 [Abstract] [Full Text]  
  • Berghagen, H., Ragnhildstveit, E., Krogsrud, K., Thuestad, G., Apriletti, J., Saatcioglu, F. (2002). Corepressor SMRT Functions as a Coactivator for Thyroid Hormone Receptor T3Ralpha from a Negative Hormone Response Element. J. Biol. Chem. 277: 49517-49522 [Abstract] [Full Text]  
  • Savory, J. G. A., Préfontaine, G. G., Lamprecht, C., Liao, M., Walther, R. F., Lefebvre, Y. A., Haché, R. J. G. (2001). Glucocorticoid Receptor Homodimers and Glucocorticoid-Mineralocorticoid Receptor Heterodimers Form in the Cytoplasm through Alternative Dimerization Interfaces. Mol. Cell. Biol. 21: 781-793 [Abstract] [Full Text]  
  • Williams, G. R. (2000). Cloning and Characterization of Two Novel Thyroid Hormone Receptor beta Isoforms. Mol. Cell. Biol. 20: 8329-8342 [Abstract] [Full Text]  
  • Ren, Y., Behre, E., Ren, Z., Zhang, J., Wang, Q., Fondell, J. D. (2000). Specific Structural Motifs Determine TRAP220 Interactions with Nuclear Hormone Receptors. Mol. Cell. Biol. 20: 5433-5446 [Abstract] [Full Text]  
  • Raval-Pandya, M., Freedman, L. P., Li, H., Christakos, S. (1998). Thyroid Hormone Receptor Does Not Heterodimerize with the Vitamin D Receptor but Represses Vitamin D Receptor-Mediated Transactivation. Mol. Endocrinol. 12: 1367-1379 [Abstract] [Full Text]  
  • Chinpaisal, C., Lee, C.-H., Wei, L.-N. (1998). Mechanisms of the Mouse Orphan Nuclear Receptor TR2-11-mediated Gene Suppression. J. Biol. Chem. 273: 18077-18085 [Abstract] [Full Text]  
  • Wahlström, G. M., Vennström, B. (1998). Requirements for Repression of Retinoid X Receptor by the Oncoprotein P75gag-v-erbA and the Thyroid Hormone Receptors. Mol. Endocrinol. 12: 645-653 [Abstract] [Full Text]  
  • Jurutka, P. W., Hsieh, J.-C., Remus, L. S., Whitfield, G. K., Thompson, P. D., Haussler, C. A., Blanco, J. C. G., Ozato, K., Haussler, M. R. (1997). Mutations in the 1,25-Dihydroxyvitamin D3 Receptor Identifying C-terminal Amino Acids Required for Transcriptional Activation That Are Functionally Dissociated from Hormone Binding, Heterodimeric DNA Binding, and Interaction with Basal Transcription Factor IIB, in Vitro. J. Biol. Chem. 272: 14592-14599 [Abstract] [Full Text]  
  • Collingwood, T. N., Butler, A., Tone, Y., Clifton-Bligh, R. J., Parker, M. G., Chatterjee, V. K. K. (1997). Thyroid Hormone-mediated Enhancement of Heterodimer Formation between Thyroid Hormone Receptor beta  and Retinoid X Receptor. J. Biol. Chem. 272: 13060-13065 [Abstract] [Full Text]  
  • Dowell, P., Peterson, V. J., Zabriskie, T. M., Leid, M. (1997). Ligand-induced Peroxisome Proliferator-activated Receptor alpha Conformational Change. J. Biol. Chem. 272: 2013-2020 [Abstract] [Full Text]  
  • Ikeda, M., Wilcox, E. C., Chin, W. W. (1996). Different DNA Elements Can Modulate the Conformation of Thyroid Hormone Receptor Heterodimer and Its Transcriptional Activity. J. Biol. Chem. 271: 23096-23104 [Abstract] [Full Text]  
  • Lefebvre, P., Gaub, M.-P., Tahayato, A., Rochette-Egly, Céc., Formstecher, P. (1995). Protein Phosphatases 1 and 2A Regulate the Transcriptional and DNA Binding Activities of Retinoic Acid Receptors. J. Biol. Chem. 270: 10806-10816 [Abstract] [Full Text]  
  • Aneskievich, B., Fuchs, E (1995). The A/B domain of truncated retinoic acid receptors can block differentiation and promote features of malignancy. J. Cell Sci. 108: 195-205 [Abstract]